dc.creator | Spiliopoulos, K. | en |
dc.creator | Giamouzis, G. | en |
dc.creator | Karayannis, G. | en |
dc.creator | Karangelis, D. | en |
dc.creator | Koutsias, S. | en |
dc.creator | Kalogeropoulos, A. | en |
dc.creator | Georgiopoulou, V. | en |
dc.creator | Skoularigis, J. | en |
dc.creator | Butler, J. | en |
dc.creator | Triposkiadis, F. | en |
dc.date.accessioned | 2015-11-23T10:48:17Z | |
dc.date.available | 2015-11-23T10:48:17Z | |
dc.date.issued | 2012 | |
dc.identifier | 10.1155/2012/574198 | |
dc.identifier.issn | 20900597 | |
dc.identifier.uri | http://hdl.handle.net/11615/33289 | |
dc.description.abstract | Heart failure is a major public health problem and its management requires a significant amount of health care resources. Even with administration of the best available medical treatment, the mortality associated with the disease remains high. As therapeutical strategies for heart failure have been refined, the number of patients suffering from the disease has expanded dramatically. Although heart transplantation still represents the gold standard therapeutical approach, the implantation of mechanical circulatory support devices (MCSDs) evolved to a well-established management for this disease. The limited applicability of heart transplantation caused by a shortage of donor organs and the concurrent expand of the patient population with end-stage heart failure led to a considerable utilization of MCSDs. This paper outlines the current status of mechanical circulatory support. © 2012 Kyriakos Spiliopoulos et al. | en |
dc.source.uri | http://www.scopus.com/inward/record.url?eid=2-s2.0-84866253550&partnerID=40&md5=39b32898a8721cf42bab5df4bd712faa | |
dc.subject | assisted circulation | en |
dc.subject | brain hemorrhage | en |
dc.subject | brain ischemia | en |
dc.subject | device approval | en |
dc.subject | device infection | en |
dc.subject | device safety | en |
dc.subject | food and drug administration | en |
dc.subject | gastrointestinal hemorrhage | en |
dc.subject | heart failure | en |
dc.subject | high risk population | en |
dc.subject | human | en |
dc.subject | intermethod comparison | en |
dc.subject | left ventricular assist device | en |
dc.subject | medical informatics | en |
dc.subject | medical information | en |
dc.subject | outcome assessment | en |
dc.subject | overall survival | en |
dc.subject | patient selection | en |
dc.subject | postoperative complication | en |
dc.subject | priority journal | en |
dc.subject | reference database | en |
dc.subject | review | en |
dc.subject | risk assessment | en |
dc.subject | risk factor | en |
dc.subject | systematic review | en |
dc.subject | treatment indication | en |
dc.title | Current status of mechanical circulatory support: A systematic review | en |
dc.type | journalArticle | en |